BH, L., SH, C., LC, W., YP, C., YJ, K., & CH, C. (2026). Association of Sodium-Glucose Cotransporter 2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists With Risk of Cataract. American journal of ophthalmology, 284, 66. https://doi.org/10.1016/j.ajo.2025.12.025
Chicago Style (17th ed.) CitationBH, Lin, Chuang SH, Wu LC, Chen YP, Kuo YJ, and Chang CH. "Association of Sodium-Glucose Cotransporter 2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists With Risk of Cataract." American Journal of Ophthalmology 284 (2026): 66. https://doi.org/10.1016/j.ajo.2025.12.025.
MLA (9th ed.) CitationBH, Lin, et al. "Association of Sodium-Glucose Cotransporter 2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists With Risk of Cataract." American Journal of Ophthalmology, vol. 284, 2026, p. 66, https://doi.org/10.1016/j.ajo.2025.12.025.